Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
RESEARCH TOOLSreports
Total Valuation
Sumitomo Dainippon Pharma Co has a market cap or net worth of ¥207.78B. The enterprise value is ¥512.70B.
Market Cap¥207.78B
Enterprise Value¥512.70B
Share Statistics
Sumitomo Dainippon Pharma Co has 397.90M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding397.90M
Owned by Insiders
Owned by Instutions
Financial Efficiency
Sumitomo Dainippon Pharma Co’s return on equity (ROE) is -2.02 and return on invested capital (ROIC) is -50.95%.
Return on Equity (ROE)-201.82%
Return on Assets (ROA)-34.71%
Return on Invested Capital (ROIC)-50.95%
Return on Capital Employed (ROCE)-90.35%
Revenue Per Employee¥74,841,967.871
Profits Per Employee-¥35,349,799.197
Employee Count4,980
Asset Turnover0.35
Inventory Turnover1.10
Valuation Ratios
The current PE Ratio of Sumitomo Dainippon Pharma Co is -0.51. Sumitomo Dainippon Pharma Co’s PEG ratio is >-0.01.
PE Ratio-0.51
PS Ratio0.51
PB Ratio1.03
Price to Fair Value1.03
Price to FCF-0.63
Price to Operating Cash Flow-0.67
PEG Ratio>-0.01
Income Statement
In the last 12 months, Sumitomo Dainippon Pharma Co had revenue of ¥372.71B and earned -¥176.04B in profits. Earnings per share was -¥443.12.
Revenue¥372.71B
Gross Profit¥225.56B
Operating Income-¥217.62B
Pretax Income-¥193.90B
Net Income-¥176.04B
EBITDA-172.69B
Earnings Per Share (EPS)-443.12
Cash Flow
In the last 12 months, operating cash flow was -¥5.67B and capital expenditures -¥10.96B, giving a free cash flow of -¥16.63B billion.
Operating Cash Flow-¥5.67B
Free Cash Flow-¥16.63B
Free Cash Flow per Share-¥41.80
Dividends & Yields
Sumitomo Dainippon Pharma Co pays an annual dividend of ¥7.00, resulting in a dividend yield of
Dividend Per Share¥7.00
Dividend Yield
Payout Ratio
Free Cash Flow Yield-159.72%
Earnings Yield-195.27%
Stock Price Statistics
Beta0.68
52-Week Price Change54.31%
50-Day Moving Average697.62
200-Day Moving Average590.24
Relative Strength Index (RSI)47.87
Average Volume (3m)2.22M
Important Dates
Sumitomo Dainippon Pharma Co upcoming earnings date is May 9, 2025, TBA.
Last Earnings DateJan 31, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend DateMar 30, 2023
Financial Position
Sumitomo Dainippon Pharma Co as a current ratio of 0.52, with Debt / Equity ratio of 2.68
Current Ratio0.52
Quick Ratio0.30
Debt to Market Cap2.60
Net Debt to EBITDA-1.39
Interest Coverage Ratio-82.81
Taxes
In the past 12 months, Sumitomo Dainippon Pharma Co has paid -¥17.89B in taxes.
Income Tax-¥17.89B
Effective Tax Rate2.53%
Enterprise Valuation
Sumitomo Dainippon Pharma Co EV to EBITDA ratio is -1.96, with an EV/FCF ratio of -2.14.
EV to Sales1.75
EV to EBITDA-1.96
EV to Free Cash Flow-2.14
EV to Operating Cash Flow-2.28
Balance Sheet
Sumitomo Dainippon Pharma Co has ¥85.39B in cash and marketable securities with ¥374.42B in debt, giving a net cash position of ¥289.03B billion.
Cash & Marketable Securities¥85.39B
Total Debt¥374.42B
Net Cash¥289.03B
Net Cash Per Share¥726.39
Tangible Book Value Per Share-¥602.33
Margins
Gross margin is 59.76%, with operating margin of -112.60%, and net profit margin of -100.13%.
Gross Margin59.76%
Operating Margin-112.60%
Pretax Margin-102.72%
Net Profit Margin-100.13%
EBITDA Margin-89.35%
EBIT Margin-101.36%
Analyst Forecast
The average price target for Sumitomo Dainippon Pharma Co is ¥836.66, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥836.66
Price Target Upside37.61%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast12.84%
EPS Growth Forecast-1.34%